Expression and modulation of cellular receptors for interferon-γ, tumour necrosis factor, and Fas on human bone marrow CD34+ cells

British Journal of Haematology

Volumn 97, Issue 2, 1997, Pages 356-365

  Sato, Tadatsugu ^a   Selleri, Carmine ^a   Anderson, Stacie ^a   Young, Neal S ^a   Maciejewski, Jaroslaw P ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

bone marrow; CD34+ cells; Fas R; IFN R; TNFR

Indexed keywords

CD34 ANTIGEN; FAS ANTIGEN; GAMMA INTERFERON; INTERFERON RECEPTOR; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031007366     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.562704.x     Document Type: Article

References (54)

1. Aggarwal, B.B. & Pandida, R. (1994) Both type I and type II interferons down-regulate human tumor necrosis factor receptors in human hepatocellular carcinoma cell line Hep G2: role for protein kinase C. FEBS Letters, 337, 99-102.
2. Aguet, M., Dembić, Z. & Merlin, G. (1988) Molecular cloning and expression of the human interferon-γ receptor. Cell, 55, 273-280.
3. Akashi, K., Hayashi, S., Gondo, H., Mizuno, S.I., Tamura, K., Yamasaki, K., Shibuya, T., Uike, N., Okamura, T., Miyamoto, T. & Niho, Y. (1994) Involvement of interferon-gamma, and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. British Journal of Haematology, 87, 243-250.
4. Broxmeyer, H.E., Williams, D.E. & Lu, L. (1986) The suppressive influences of human tumor necrosis factors on bone marrow progenitor cells from normal donors and from patients with leukemia: synergism of tumor necrosis factor and interferon-γ. Journal of Immunology, 13, 4487-4495.
5. + hematopoietic progenitor cells. Blood, 79, 2628-2635.
6. + hematopoietic progenitor cells. Blood, 75, 2292-2298.
7. Chen, P.C., DuBois, G.C. & Chen, M.J. (1995) Mapping the domain(s) critical for the binding of human tumor necrosis factor-alpha to its two receptors. Journal of Biological Chemistry, 270, 2877-2878.
8. Cheng, J., Liu, C., Koopman, W.J. & Mountz, J.D. (1995) Characterization of human Fas gene: exon/intron organization and promoter region. Journal of Immunology, 154, 1239-1245.
9. Darnell, J.E., Jr. Kerr, I.M. & Stark, G.R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science, 264, 1415-1421.
10. Farrar, M.A. & Schreiber, R.D. (1993) The molecular cell biology of interferon-γ and its receptor. Annual Review of Immunology, 11, 571-611.
11. Gruss, H.-J. & Dower, S.K. (1995) Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood, 85, 3378-3404.
12. Heller, R.A. & Krönke, M. (1994) Tumor necrosis factor receptor-mediated signaling pathways. Journal of Cellular Biology, 126, 5-9.
13. Hintenberger, W., Adolf, G. & Bettelheim, P. (1989) Lymphokine overproduction in severe aplastic anemia is not related to blood transfusions. Blood, 74, 2713-2717.
14. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y. & Nagata, S. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell, 66, 233-243.
15. Johnson, R.A., Waddelow, T.A., Caro, J., Oliff, A. & Roodman, G.D. (1989) Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood, 74, 130-138.
16. Kalthoff, H., Roeder, C., Brockhaus, M., Thiele, H.-G. & Schmiegel, W. (1993) Tumor necrosis factor (TNF) up-regulates the expression of p75 but not p55 TNF receptors, and both receptors mediate, independently of each other, up-regulation of transforming growth factor α and epidermal growth factor receptor mRNA. Journal of Biological Chemistry, 268, 2762-2766.
17. Katevas, P., Maciejewski, J.P., Sorrentino, B. & Young, N.S. (1993) Increased expression of TNF-beta in patients with aplastic anemia. Blood, 82, (Suppl.). 345a.
18. Kawano, Y., Takaue, Y., Hirao, A., Abe, T., Saito, S.I., Matsunaga, K., Watanabe, T., Hirose, M., Ninomiya, T., Kuroda, Y., Yokobayashi, A. & Asano, S. (1991) Synergistic effect of recombinant interferon-γ-and interleukin-3 on the growth of immature human hematopoietic progenitors. Blood, 77, 2118-2121.
19. + cells via p55 TNFα receptors. Blood, 84, 2506-2514.
20. Krause, D.S., Fackler, M.J., Civin, C.I. & May, W.S. (1996) CD34: structure, biology, and clinical utility. Blood, 87, 1-13.
21. Kuhnert, P., Kemper, O. & Wallach, D. (1994) Cloning, sequencing and partial functional characterization of the 5′ region of the human p75 tumor necrosis factor-encoding gene (TNF-R). Gene, 150, 381-386.
22. + human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood, 85, 3183-3190.
23. + cells of patients with aplastic anaemia. British Journal of Haematology, 91, 245-252.
24. Means, R.T. & Krantz, S.B. (1993) Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. Journal of Clinical Investigation, 91, 416-419.
25. Molinas, F.C., Witzebin, J. & Falcoff, E. (1987) Human platelets possess receptors for a lymphokine: demonstration for high specific receptor for HuIFN-γ. Journal of Immunology, 138, 802-807.
26. Nagafuji, K., Shibuya, T., Harada, M., Mizuno, S., Takenaka, K., Miyamoto, T., Okamura, T., Gondo, H. & Niho, Y. (1995) Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood, 86, 883-889.
27. Nagata, S. & Golstein, P. (1995) The Fas death factor. Science, 267, 1449-1456.
28. Nakao, S., Yamaguchi, M. & Shiobara, S. (1992) Interferon-γ gene expression in unstimulated bone marrow mononuclear cells predicts a response to cyclosporine therapy in aplastic anemia. Blood, 79, 2532-2535.
29. Nisticò, A. & Young, N.S. (1994) Gamma-interferon gene expression in the bone marrow of patients with acquired aplastic anemia. Annals of Internal Medicine, 120, 463-469.
30. Novelli M., Di Pierro, F., Di Celle, P.F., Bertini, S., Affaticati, P., Garotta, G. & Forni, G. (1994) Environmental signals influencing expression of the IFN-γ receptor on human T cells control whether IFN-γ promotes proliferation or apoptosis. Journal of Immunology, 152, 496-504.
31. Oehm, A., Behrman, I., Falk, W. & Pawlita, M. (1992) Purification and molecular cloning of the Apo-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen. Journal of Biological Chemistry, 267, 10709-10715.
32. Quesada, J.R., Talpaz, M., Rios, A., Kurzrock, R. & Gutterman, J.U. (1986) Clinical toxicity of interferons in cancer patients. Journal of Clinical Oncology, 4, 234-243.
33. Rigby, W.G.C., Ball, E.D., Guyre, P.M. & Fanger, M.W. (1985) The effects of recombinant DNA-derived interferons on the growth of myeloid progenitor cells. Blood, 65, 858-861.
34. Roodman, G.D., Bird, A., Hutzler, D. & Montgomery, W. (1987) Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell line K562, HL60 and HEL cells. Experimantal Hematology, 15, 928-932.
35. Rosseli, F., Sanceau, J., Gluckman, E., Wietzerbin, J. & Moustacchi, E. (1994) Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha. Blood, 83, 1216-1225.
36. Rusten, L.S., Jacobsen, F.W., Lesslauer, W., Loetscher, R., Gentz, R. & Jacobsen, S.E.W. (1994a) Bifunctional effects of TNF-α on the growth of mature and primitive human hematopoietic progenitor cells. Blood, 83, 3152-3159.
37. Rusten, L.S., Smeland, E.B., Jacobsen, F.W., Lien, E., Lesslauer, W., Loetscher, H., Dubois, C.M. & Jacobsen, S.E.W. (1994b) Tumor necrosis factor-α inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Journal of Clinical Investigation, 94, 165-172.
38. Saks, S. & Rosemblum, M. (1992) Recombinant human TNF-alpha: preclinical studies and results from early clinical trials. Immunology, 56, 567-587.
39. Sato, T. Selleri, C., Young, N.S. & Maciejewski, J.P. (1995) Hematopoietic inhibition by interferon-γ is partially mediated through interferon regulatory factor-1. Blood, 86, 3373-3380.
40. Seipelt, G., Ganser, A., Duranceyk, H., Maurer, A., Ottman, O.G. & Holzer, D. (1993) Induction of TNF-alpha in patients with myelodysplastic syndromes undergoing treatment with interleukin-3. British Journal of Haematology, 84, 749-751.
41. Selleri, C., Sato, T., Anderson, S., Young, N.S. & Maciejewski, J.P. (1995) Interferon-γ and tumor necrosis factor-α suppress both early and late stages of hematopoiesis and induce programmed cell death. Journal of Cellular Physiology, 165, 538-546.
42. Smith, C.A., Farrah, T. & Goodwin, R.G. (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell, 76, 959-962.
43. + human hematopoietic progenitor cells. Journal of Experimental Medicine, 180, 1177-1182.
44. Soh, J., Donnelly, R.J., Kotenko, S., Mariano, T.M., Cook, J.R., Wang, N., Emanuel, S., Schwartz, B., Miki, T. & Pestka, S. (1994) Identification and sequence of an accessory factor required for activation of the human interferon γ receptor. Cell, 76, 793-802.
45. Tracy, K.J. & Cerami, A. (1994) Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annual Review of Medicine, 45, 491-503.
46. Ucer, U., Bratsch, H., Scheurich, P., Berkovic, D., Ertel, C. & Pfizenmaier, K. (1986) Quantitation and characterization of γ-interferon receptors on human tumor cells. Cancer Research, 46, 5339-5343.
47. Valente, G., Ozmen, L., Novelli, F., Geuna, M., Palestro, G., Forni, G. & Garotta, G. (1992) Distribution of interferon-γ receptor in human tissues. European Journal of Immunology, 22, 2403-2412.
48. Vandenabeele, P., Declercq, W., Beyaert, R. & Fiers, W. (1995) Two tumor necrosis factor receptors: structure and function. Trends in Cell Biology, 5, 392-399.
49. Verhoef, G.E., Schouwer, P., Ceuppens, J.L., Van Damme, J.O., Goossens, W. & Boogaerts, M.A. (1992) Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia, 6, 1268-1272.
50. Viale, M., Merli, A. & Bacigalupo, A. (1991) Analysis at the clonal level of T-cell phenotype and functions in severe aplastic anemia patients. Blood, 78, 1268-1274.
51. Winzen, R., Wallach, D., Kemper, O., Resch, K. & Holtmann, H. (1993) Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. Journal of Immunology, 150, 4346-4353.
52. Young, H.A. & Hardy, K.J. (1995) Role of interferon-γ in immune cell regulation. Journal of Leukocyte Biology, 58, 373-381.
53. Zoumbos, N.C., Djeu, J.Y. & Young, N.S. (1984) Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro. Journal of Immunology, 133, 769-774.
54. Zoumbos, N.C., Gascon, P., Djeu, J.Y. & Young, N.S. (1985) Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proceedings of the National Academy of Sciences of the United States of America, 82, 188-192.